NTRK1 and neoplasm: For instance, expression of TPR-NTRK1 fusion kinase in immortal mouse lung epithelial cells, fuelled the tumor growth [154], the same cells exhibited a dramatic suppression of in vivo drug resistance on being administered entrectinib + cobimetinib (a MEK1/2 inhibitor).